The Vanguard Group 13D and 13G filings for Cardlytics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Sale |
2023-12-29 | 13G | Cardlytics, Inc. CDLX |
The Vanguard Group | 2,153,790 5.490% |
-238,967 (-9.99%) |
Filing |
| 2023-02-09 11:12 am Sale |
2022-12-30 | 13G | Cardlytics, Inc. CDLX |
The Vanguard Group | 2,392,757 7.210% |
-512,285 (-17.63%) |
Filing |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | Cardlytics, Inc. CDLX |
The Vanguard Group | 2,905,042 8.730% |
1,068,299 (+58.16%) |
Filing |
| 2021-02-10 10:39 am Purchase |
2020-12-31 | 13G | Cardlytics, Inc. CDLX |
The Vanguard Group | 1,836,743 6.690% |
1,836,743 (New Position) |
Filing |